Cargando…
RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
Mutation in RAS proteins is one of the most common genetic alterations observed in human and experimentally induced rodent cancers. In vivo, oncogenic mutations have been shown to occur at exons 12, 13, and 61, resulting in any 1 of 19 possible point mutations in a given tumor for a specific RAS iso...
Autores principales: | Miller, Mark Steven, Miller, Lance D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262225/ https://www.ncbi.nlm.nih.gov/pubmed/22303394 http://dx.doi.org/10.3389/fgene.2011.00100 |
Ejemplares similares
-
Inhibition of
EGFR Signaling: All Mutations Are Not Created Equal
por: Gazdar, Adi F, et al.
Publicado: (2005) -
Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation
por: Kikuchi, Yasuko, et al.
Publicado: (2013) -
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
por: Bunda, Severa, et al.
Publicado: (2015) -
BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications
por: Oikonomou, Eftychia, et al.
Publicado: (2014) -
Ras protein abundance correlates with Ras isoform mutation patterns in cancer
por: Hood, Fiona E., et al.
Publicado: (2023)